AHR
AHR
American Healthcare REIT, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $650.77M ▲ | $-50.98M ▼ | $23.71M ▲ | 3.64% ▲ | $0.13 ▲ | $109.34M ▲ |
| Q4-2025 | $604.08M ▲ | $-39.06M ▼ | $10.78M ▼ | 1.78% ▼ | $0.06 ▼ | $83.65M ▼ |
| Q3-2025 | $572.94M ▲ | $75.93M ▲ | $55.93M ▲ | 9.76% ▲ | $0.33 ▲ | $84.73M ▼ |
| Q2-2025 | $542.5M ▲ | $69.87M ▲ | $9.91M ▲ | 1.83% ▲ | $0.06 ▲ | $84.78M ▲ |
| Q1-2025 | $540.6M | $67.91M | $-6.8M | -1.26% | $-0.04 | $67.64M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $119.38M ▲ | $5.6B ▲ | $2.08B ▲ | $3.48B ▲ |
| Q4-2025 | $114.84M ▼ | $5.43B ▲ | $2.07B ▲ | $3.32B ▲ |
| Q3-2025 | $147.36M ▲ | $4.77B ▲ | $2.05B ▲ | $2.68B ▲ |
| Q2-2025 | $133.49M ▲ | $4.51B ▲ | $2.04B ▼ | $2.42B ▲ |
| Q1-2025 | $86.06M | $4.46B | $2.16B | $2.26B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $24.01M ▲ | $88.06M ▲ | $-203.09M ▲ | $128.64M ▼ | $13.61M ▲ | $49.74M ▲ |
| Q4-2025 | $10.94M ▼ | $55.16M ▼ | $-709.58M ▼ | $621.81M ▲ | $-32.61M ▼ | $-14.09M ▼ |
| Q3-2025 | $55.93M ▲ | $107.19M ▲ | $-278.46M ▼ | $185.69M ▲ | $14.37M ▼ | $155.26M ▲ |
| Q2-2025 | $10.08M ▲ | $71.47M ▲ | $-62.09M ▼ | $33.12M ▲ | $42.54M ▲ | $44.58M ▲ |
| Q1-2025 | $-6.84M | $60.62M | $-32.78M | $-23.78M | $4.15M | $39.44M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Resident Fees and Services | $500.00M ▲ | $530.00M ▲ | $560.00M ▲ | $610.00M ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
NonUS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $540.00M ▲ | $570.00M ▲ | $600.00M ▲ | $650.00M ▲ |
International | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at American Healthcare REIT, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives for American Healthcare REIT include a sizable and diversified portfolio of healthcare properties, exceptionally strong property‑level profitability, and robust operating cash flow that remains positive even after capital spending. The company has built a differentiated position in integrated senior health campuses and has deep relationships with quality operators, which can support occupancy and stability. Its ability to execute large acquisitions, invest in property improvements, and deploy practical efficiency and ESG initiatives further underpin the strength of its platform.
On the risk side, AHR operates with thin net margins and a history of accumulated losses, indicating limited cushion if conditions worsen. Leverage is significant and liquidity metrics are tight, meaning the company depends heavily on prudent financing and continued access to debt and equity markets. Large balances of goodwill and other intangibles introduce potential impairment risk if acquisitions underperform. The business is also exposed to operator health, labor pressures, reimbursement and regulatory changes, and competition from other well‑capitalized healthcare investors, all of which can affect cash flows and asset values.
Looking forward, the backdrop of aging demographics and rising demand for senior and post‑acute care is favorable for AHR’s core asset types, offering a supportive long‑term tailwind. Whether this translates into stronger profitability and a more resilient balance sheet will depend on the company’s ability to sustain high occupancy, pass through cost inflation, integrate new acquisitions effectively, and gradually reduce financial risk. The early evidence points to a solid operating franchise but a capital‑intensive, finely balanced financial profile, so outcomes will likely be sensitive to both execution quality and broader credit and healthcare conditions.
About American Healthcare REIT, Inc.
https://www.americanhealthcarereit.comAmerican Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare Investors.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $650.77M ▲ | $-50.98M ▼ | $23.71M ▲ | 3.64% ▲ | $0.13 ▲ | $109.34M ▲ |
| Q4-2025 | $604.08M ▲ | $-39.06M ▼ | $10.78M ▼ | 1.78% ▼ | $0.06 ▼ | $83.65M ▼ |
| Q3-2025 | $572.94M ▲ | $75.93M ▲ | $55.93M ▲ | 9.76% ▲ | $0.33 ▲ | $84.73M ▼ |
| Q2-2025 | $542.5M ▲ | $69.87M ▲ | $9.91M ▲ | 1.83% ▲ | $0.06 ▲ | $84.78M ▲ |
| Q1-2025 | $540.6M | $67.91M | $-6.8M | -1.26% | $-0.04 | $67.64M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $119.38M ▲ | $5.6B ▲ | $2.08B ▲ | $3.48B ▲ |
| Q4-2025 | $114.84M ▼ | $5.43B ▲ | $2.07B ▲ | $3.32B ▲ |
| Q3-2025 | $147.36M ▲ | $4.77B ▲ | $2.05B ▲ | $2.68B ▲ |
| Q2-2025 | $133.49M ▲ | $4.51B ▲ | $2.04B ▼ | $2.42B ▲ |
| Q1-2025 | $86.06M | $4.46B | $2.16B | $2.26B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $24.01M ▲ | $88.06M ▲ | $-203.09M ▲ | $128.64M ▼ | $13.61M ▲ | $49.74M ▲ |
| Q4-2025 | $10.94M ▼ | $55.16M ▼ | $-709.58M ▼ | $621.81M ▲ | $-32.61M ▼ | $-14.09M ▼ |
| Q3-2025 | $55.93M ▲ | $107.19M ▲ | $-278.46M ▼ | $185.69M ▲ | $14.37M ▼ | $155.26M ▲ |
| Q2-2025 | $10.08M ▲ | $71.47M ▲ | $-62.09M ▼ | $33.12M ▲ | $42.54M ▲ | $44.58M ▲ |
| Q1-2025 | $-6.84M | $60.62M | $-32.78M | $-23.78M | $4.15M | $39.44M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Resident Fees and Services | $500.00M ▲ | $530.00M ▲ | $560.00M ▲ | $610.00M ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
NonUS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $540.00M ▲ | $570.00M ▲ | $600.00M ▲ | $650.00M ▲ |
International | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at American Healthcare REIT, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives for American Healthcare REIT include a sizable and diversified portfolio of healthcare properties, exceptionally strong property‑level profitability, and robust operating cash flow that remains positive even after capital spending. The company has built a differentiated position in integrated senior health campuses and has deep relationships with quality operators, which can support occupancy and stability. Its ability to execute large acquisitions, invest in property improvements, and deploy practical efficiency and ESG initiatives further underpin the strength of its platform.
On the risk side, AHR operates with thin net margins and a history of accumulated losses, indicating limited cushion if conditions worsen. Leverage is significant and liquidity metrics are tight, meaning the company depends heavily on prudent financing and continued access to debt and equity markets. Large balances of goodwill and other intangibles introduce potential impairment risk if acquisitions underperform. The business is also exposed to operator health, labor pressures, reimbursement and regulatory changes, and competition from other well‑capitalized healthcare investors, all of which can affect cash flows and asset values.
Looking forward, the backdrop of aging demographics and rising demand for senior and post‑acute care is favorable for AHR’s core asset types, offering a supportive long‑term tailwind. Whether this translates into stronger profitability and a more resilient balance sheet will depend on the company’s ability to sustain high occupancy, pass through cost inflation, integrate new acquisitions effectively, and gradually reduce financial risk. The early evidence points to a solid operating franchise but a capital‑intensive, finely balanced financial profile, so outcomes will likely be sensitive to both execution quality and broader credit and healthcare conditions.

CEO
Jeff Hanson
Compensation Summary
(Year 2025)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 230
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
UBS
Buy
Barclays
Overweight
Citigroup
Buy
Scotiabank
Sector Outperform
Keybanc
Overweight
RBC Capital
Outperform
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:28.74M
Value:$1.56B
VANGUARD GROUP INC
Shares:24.97M
Value:$1.35B
STATE STREET CORP
Shares:9.55M
Value:$517.25M
Summary
Showing Top 3 of 614

